Clinical Trial Update: Retrospective Follow-up Study of Synvisc® in Patients With Knee Osteoarthritis

View source ↗

Summary

This document reports the completion of a retrospective follow-up study evaluating Synvisc (hylan G-F 20) in patients with knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Synvisc (Hylan G-F 20)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Osteoarthritis | Status: COMPLETED